Steroid treatments in mice do not alter the number and function of regulatory T cells, but amplify cyclophosphamide-induced autoimmune disease.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Autoimmunity

• Publication date

  2009-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.jaut.2009.03.008PMID 19362805
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Compromised CD4+ CD25high regulatory T‐cell function in patients with relapsing‐remitting multiple sclerosis is correlated with a reduced frequency of FOXP3‐positive cells and reduced FOXP3 expression at the single‐cell level

  2008cited by this paper
• Launching the T-cell-lineage developmental programme

  2008cited by this paper
• Clinical significance of increased CD4+CD25−Foxp3+ T cells in patients with new-onset systemic lupus erythematosus

  2008cited by this paper
• Circulating dendritic cells subsets and CD4+Foxp3+ regulatory T cells in adult patients with chronic ITP before and after treatment with high‐dose dexamethasome

  2007cited by this paper
• [The changes of CD4(+) CD25(high) regulatory T cells in the course of rheumatoid arthritis and their significances].

  2007cited by this paper
• TLR4 Hyperresponsiveness via Cell Surface Expression of Heat Shock Protein gp96 Potentiates Suppressive Function of Regulatory T Cells1

  2007cited by this paper
• Regulation of differential pro- and anti-apoptotic signaling by glucocorticoids

  2007cited by this paper
• The quantitative analysis of peripheral blood FOXP3‐expressing T cells in systemic lupus erythematosus and rheumatoid arthritis patients

  2007cited by this paper
• Increased frequency of CD4+ CD25+ regulatory T cells in the cerebrospinal fluid but not in the blood of multiple sclerosis patients

  2007cited by this paper
• Prevalence of Newly Generated Naive Regulatory T Cells (Treg) Is Critical for Treg Suppressive Function and Determines Treg Dysfunction in Multiple Sclerosis1

  2007cited by this paper
• Pertussis toxin as an adjuvant suppresses the number and function of CD4+CD25+ T regulatory cells

  2006cited by this paper
• Secondary progressive in contrast to relapsing‐remitting multiple sclerosis patients show a normal CD4+CD25+ regulatory T‐cell function and FOXP3 expression

  2006cited by this paper
• Cyclophosphamide-Induced Type-1 Diabetes in the NOD Mouse Is Associated with a Reduction of CD4+CD25+Foxp3+ Regulatory T Cells1

  2006cited by this paper
• CD4+CD25+FoxP3+ T lymphocytes fail to suppress myelin basic protein-induced proliferation in patients with multiple sclerosis.

  2006cited by this paper
• Circulating dendritic cells subsets and regulatory T-cells at multiple sclerosis relapse: differential short-term changes on corticosteroids therapy.

  2006cited by this paper
• Glucocorticoid amplifies IL‐2‐dependent expansion of functional FoxP3+CD4+CD25+ T regulatory cells in vivo and enhances their capacity to suppress EAE

  2006cited by this paper
• Pertussis Toxin Reduces the Number of Splenic Foxp3+ Regulatory T Cells1

  2006cited by this paper
• Regulatory T cells in patients with systemic lupus erythematosus.

  2006cited by this paper
• Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis.

  2005cited by this paper
• Inhibition of CD4(+)25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide.

  2005cited by this paper
• Glucocorticoid-induced apoptosis and glucocorticoid resistance in acute lymphoblastic leukemia.

  2005cited by this paper
• Global Natural Regulatory T Cell Depletion in Active Systemic Lupus Erythematosus1

  2005cited by this paper
• Foxp3+ CD25- CD4 T cells constitute a reservoir of committed regulatory cells that regain CD25 expression upon homeostatic expansion.

  2005cited by this paper
• Respiratory Tolerance Is Inhibited by the Administration of Corticosteroids1

  2005cited by this paper
• Reduced suppressive effect of CD4+CD25high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis

  2005cited by this paper
• Loss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple Sclerosis

  2004cited by this paper
• Differential response of murine CD4+CD25+ and CD4+CD25– T cells to dexamethasone‐induced cell death

  2004cited by this paper
• Compromised Function of Regulatory T Cells in Rheumatoid Arthritis and Reversal by Anti-TNFα Therapy

  2004cited by this paper
• Decreased CD4+CD25+ T Cells in Peripheral Blood of Patients with Systemic Lupus Erythematosus

  2004cited by this paper
• Sequential therapies for proliferative lupus nephritis.

  2004cited by this paper
• Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma.

  2004influential reference
• Quantification of regulatory T cells in patients with systemic lupus erythematosus.

  2003cited by this paper
• Glucocorticoids and invasive fungal infections.

  2003cited by this paper
• Regulatory T Cells Selectively Express Toll-like Receptors and Are Activated by Lipopolysaccharide

  2003cited by this paper
• Cutting Edge: Cure of Colitis by CD4+CD25+ Regulatory T Cells1

  2003cited by this paper
• Continuous Activation of Autoreactive CD4+ CD25+ Regulatory T Cells in the Steady State

  2003cited by this paper
• Myelin Oligodendrocyte Glycoprotein–specific T Cell Receptor Transgenic Mice Develop Spontaneous Autoimmune Optic Neuritis

  2003cited by this paper
• Specificity requirements for selection and effector functions of CD25+4+ regulatory T cells in anti-myelin basic protein T cell receptor transgenic mice

  2002cited by this paper
• Peripheral expansion of thymus‐derived regulatory cells in anti‐myelin basic protein T cell receptor transgenic mice

  2002cited by this paper
• Keeping up appearances

  2002cited by this paper
• Reversible Disruption of Thymic Function by Steroid Treatment1

  2002cited by this paper
• Interleukin 2 Signaling Is Required for CD4+ Regulatory T Cell Function

  2002cited by this paper
• Mechanism of action of glucocorticosteroid hormones: possible implications for therapy of neuroimmunological disorders.

  2001cited by this paper
• Regulatory T cells in spontaneous autoimmune encephalomyelitis

  2001cited by this paper
• T-cell apoptosis in situ in experimental autoimmune encephalomyelitis following methylprednisolone pulse therapy.

  2000cited by this paper
• Fulminant spontaneous autoimmunity of the central nervous system in mice transgenic for the myelin proteolipid protein-specific T cell receptor.

  2000cited by this paper
• Neonatal Dexamethasone Treatment Increases Susceptibility to Experimental Autoimmune Disease in Adult Rats1

  2000cited by this paper
• Repertoire Requirements of CD4+ T Cells That Prevent Spontaneous Autoimmune Encephalomyelitis1

  2000cited by this paper
• Equivalent doses and relative drug potencies for non-genomic glucocorticoid effects: a novel glucocorticoid hierarchy.

  1999influential reference
• Regulatory CD4+ T Cells Expressing Endogenous T Cell Receptor Chains Protect Myelin Basic Protein–specific Transgenic Mice from Spontaneous Autoimmune Encephalomyelitis

  1998cited by this paper
• CD4+ T Cells Prevent Spontaneous Experimental Autoimmune Encephalomyelitis in Anti–Myelin Basic Protein T Cell Receptor Transgenic Mice

  1998cited by this paper
• Correlating notch signaling with thymocyte maturation.

  1998cited by this paper
• Genetic dissection of glucocorticoid receptor function in mice.

  1998cited by this paper
• Analysis of intestinal lymphocytes in mouse colitis mediated by transfer of CD4+, CD45RBhigh T cells to SCID recipients.

  1997cited by this paper
• Tolerance Induction and Autoimmune Encephalomyelitis Amelioration After Administration of Myelin Basic Protein–derived Peptide

  1997cited by this paper
• Methylprednisolone inhibits uptake of Ca2+ and Na+ ions into concanavalin A-stimulated thymocytes.

  1997cited by this paper
• Modulated expression of notch1 during thymocyte development

  1996cited by this paper
• Modulated expression of notch1 during thymocyte development.

  1996cited by this paper
• Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation

  1996cited by this paper
• Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases.

  1995cited by this paper
• Emerging diversities in the mechanism of action of steroid hormones.

  1995cited by this paper
• Organ‐specific autoimmunity induced by adult thymectomy and cyclophosphamide‐induced lymphopenia

  1995cited by this paper
• Molecular mechanisms of action of steroid/thyroid receptor superfamily members.

  1994cited by this paper
• Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells.

  1994cited by this paper
• A reduction in serum glucocorticoids provokes experimental allergic encephalomyelitis

  1994cited by this paper
• High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice.

  1994influential reference
• Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity.

  1993cited by this paper
• CD4+ T cells that express high levels of CD45RB induce wasting disease when transferred into congenic severe combined immunodeficient mice. Disease development is prevented by cotransfer of purified CD4+ T cells

  1993cited by this paper
• Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice.

  1993cited by this paper
• Clinical Pharmacokinetics of Cyclophosphamide

  1991cited by this paper
• bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes.

  1991cited by this paper
• Steroid sensitivity of thymocyte subpopulations during intrathymic differentiation. Effects of 17 beta-estradiol and dexamethasone on subsets expressing T cell antigen receptor or IL-2 receptor.

  1989cited by this paper
• Anti‐suppressor effect of cyclophosphamide on the development of spontaneous diabetes in nod mice

  1988cited by this paper
• Dual immunofluorescence studies of cortisone-induced thymic involution: evidence for a major cortical component to cortisone-resistant thymocytes.

  1986cited by this paper
• Promotion of spontaneous diabetes in non-obese diabetes-prone mice by cyclophosphamide

  1984cited by this paper
• Clinical Pharmacokinetics of Cyclophosphamide

  1979cited by this paper
• Functional aspects of the selective depletion of lymphoid tissue by cyclophosphamide.

  1972cited by this paper
• The effect of a hormone of the adrenal cortex (17-hydroxy-11-dehydrocorticosterone; compound E) and of pituitary adrenocorticotropic hormone on rheumatoid arthritis.

  1949cited by this paper

• Dual peptide nanoparticle platform for enhanced antigen-specific immune tolerance for the treatment of experimental autoimmune encephalomyelitis.

  2022cites this paper
• Interruption of Thymic Activity in Adult Mice Improves Responses to Tumor Immunotherapy

  2021cites this paper
• Interruption of thymic activity in adults improves responses to tumor immunotherapy

  2020cites this paper
• Immunotherapy for ANCA-associated vasculitis during the COVID-19 pandemic.

  2020cites this paper
• The effects of freeze-dried Ganoderma lucidum mycelia on a recurrent oral ulceration rat model

  2017cites this paper
• Aspects of inflammation, angiogenesis and coagulation in preeclampsia

  2016cites this paper
• Brain Tumor Immunotherapy: What have We Learned so Far?

  2015cites this paper
• Regulatory T‐cell Subpopulations in Severe or Early‐onset Preeclampsia

  2015cites this paper
• Synthesis and anti-cancer evaluation of steroidal diglycoside–pyrazoline hybrids

  2014cites this paper
• A novel nanoparticle containing MOG peptide with BTLA induces T cell tolerance and prevents multiple sclerosis.

  2014cites this paper
• Influence of pharmacological immunomodulatory agents on CD4(+)CD25(high)FoxP3(+) T regulatory cells in humans.

  2013cites this paper
• regulatory cells in humans

  2013cites this paper
• Influence of pharmacological immunomodulatory agents on CD4CD25FoxP3 T regulatory cells in humans☆

  2013cites this paper
• Phenotypical and functional alterations of CD8 regulatory T cells in primary biliary cirrhosis.

  2010cites this paper
• Drugs and autoimmunity--a contemporary review and mechanistic approach.

  2010cites this paper
• Autoimmunity in 2009.

  2010cites this paper